Skip to main content

Day: February 7, 2024

MasterCraft Boat Holdings, Inc. Reports Results for Fiscal 2024 Second Quarter

VONORE, Tenn., Feb. 07, 2024 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2024 second quarter ended December 31, 2023. The highlights, commentary, and results provided herein relate to our continuing operations. Highlights:Net sales for the second quarter was $99.5 million, down 37.5% from the prior-year period Net income from continuing operations was $5.9 million, or $0.35 per diluted share Diluted Adjusted Net Income per share, a non-GAAP measure, was $0.37, down 69.2% from the prior-year period Adjusted EBITDA, a non-GAAP measure, was $9.8 million, down 67.2% from the prior-year period Share repurchases of $4.4 million during the quarter Ended the quarter with cash and investments of $108.8 millionFred Brightbill, Chief Executive Officer and Chairman,...

Continue reading

Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period

Baltic Horizon Fund publishes interest rate applicable to the fund’s 5-year bonds (ISIN: EE3300003235) for the next 3-months interest period which starts on 8 February 2024. The annual interest rate applicable to the bonds for the interest period as referred above is 8% + 3.932% (EURIBOR 3-months) totaling 11.932% per annum. For additional information, please contact: Tarmo Karotam Baltic Horizon Fund manager E-mail tarmo.karotam@nh-cap.com www.baltichorizon.com Baltic Horizon Fund is a registered contractual public closed-end real estate fund managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS. Distribution: Nasdaq, GlobeNewswire, www.baltichorizon.com To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on www.baltichorizon.com. You can also...

Continue reading

Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period

Baltic Horizon Fund publishes interest rate applicable to the fund’s 5-year bonds (ISIN: EE3300003235) for the next 3-months interest period which starts on 8 February 2024. The annual interest rate applicable to the bonds for the interest period as referred above is 8% + 3.932% (EURIBOR 3-months) totaling 11.932% per annum. For additional information, please contact: Tarmo Karotam Baltic Horizon Fund manager E-mail tarmo.karotam@nh-cap.com www.baltichorizon.com Baltic Horizon Fund is a registered contractual public closed-end real estate fund managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS. Distribution: Nasdaq, GlobeNewswire, www.baltichorizon.com To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on www.baltichorizon.com. You can also...

Continue reading

Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

SAN DIEGO, Feb. 07, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will participate at the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference on February 13-14 and conduct a virtual presentation. The virtual presentation will take place on Wednesday, February 14, 2024, at 12:40 pm ET. A webcast of the presentation can be accessed under the “Events” tab on the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The replay will be archived for 90 days following the presentation date. About Belite...

Continue reading

Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

CAMBRIDGE, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1×1 investor meetings at the Oppenheimer 34th Annual Healthcare Life Sciences Conference. Oppenheimer 34th Annual Healthcare Life Sciences Conference Fireside Chat: Wednesday, February 14, 2024 at 10:00 am ET Location: Virtual A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com. About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media...

Continue reading

Infineon and Worksport collaborate to reduce weight and cost of portable power stations with GaN

Munich, Germany and West Seneca, NY, USA, Feb. 07, 2024 (GLOBE NEWSWIRE) — Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) has announced a collaboration with Worksport Ltd. (Nasdaq: WKSP;). Worksport will use Infineon’s GaN power semiconductors GS-065-060-5-B-A in the converters for its portable power stations to increase efficiency and power density. Enabled by Infineon’s GaN transistors, the power converters will be lighter and smaller in size with reduced system costs. In addition, Infineon will support Worksport in the optimization of circuits and layout design to further reduce size and increase power density. “Infineon’s high-quality standard and solid supply chain provide us with the best components to ensure power-dense converters for our COR system product line and contribute to a first-class end product performance,”...

Continue reading

Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™

New data show additional improvement and stabilization in clinical outcomes in MPS II with 104 weeks of tividenofusp alfa (DNL310) treatment in the open-label, single-arm Phase 1/2 study; sustained normalization of CSF heparan sulfate and robust, sustained reduction in neurofilament light chain (NfL) observed Announcing initiation of dosing with DNL126 (ETV:SGSH) in Phase 1/2 study in MPS IIIA and new supportive data with MPS IIIA mice showing reductions in heparan sulfate correlated with improvements in cognitive functionSOUTH SAN FRANCISCO, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for the treatment of neurodegenerative diseases and lysosomal storage diseases,...

Continue reading

Cheetah Net Supply Chain Service Inc. Completes Edward Acquisition

CHARLOTTE, N.C., Feb. 07, 2024 (GLOBE NEWSWIRE) — Cheetah Net Supply Chain Service Inc. (“Cheetah” or the “Company”) (Nasdaq CM: CTNT) today announced the successful completion of its acquisition of Edward Transit Express Group Inc. (the “Acquisition”), a California-based global inbound non-vessel operating common carrier providing ocean and air transportation services (“Edward”). The Acquisition marks a pivotal achievement in Cheetah’s strategic expansion plans. Tony Liu, Chairman and CEO, commented, “[t]he Acquisition positions us as a more visible competitor in our industry. This strategic move aligns seamlessly with our broader goals, strengthens our logistical capabilities, and enables us to provide end-to-end supply chain solutions. We are committed to leveraging the Acquisition by reducing transaction costs, creating new...

Continue reading

Interactive Strength Inc. (Nasdaq: TRNR) Completes Acquisition of CLMBR, Creating a High-growth, B2B Focused, Connected Fitness Platform

The combined business is anticipated to generate between $15 million and $20 million in revenue in 2024, driven primarily by B2B sales to gyms, fitness studios and multi-family residential Equipment sales are expected to be largely generated by distributors, including WOODWAY, with minimal marketing expenditure The business is anticipated to be cashflow positive and adjusted EBITDA profitable potentially as early as the fourth quarter of 2024AUSTIN, TX, Feb. 07, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Interactive Strength Inc. (Nasdaq: TRNR) (“TRNR” or “the Company”), maker of premium smart home gyms and provider of virtual personal training services under the FORME brand, today announced that it has completed the acquisition of substantially all of the assets of CLMBR, Inc., (“CLMBR”) the maker of the first-to-market connected...

Continue reading

RBio Energy Corporation to Become a Public Company through a Business Combination with Perception Capital Corp. III

Transaction expected to catalyze RBio Energy’s planned development of biorefinery assets and biomass and biogas power generation capacity RBio Energy to grow platform through expected acquisitions Merger anticipated to close in second quarter 2024; combined company anticipated to list on the Nasdaq Stock Market ABERDEEN, Wash. and NEW YORK, Feb. 07, 2024 (GLOBE NEWSWIRE) — RBio Energy Corporation, which plans to develop clean energy projects (“RBio Energy”) and Perception Capital Corp. III., a special purpose acquisition company (Nasdaq: PFTA, PFTAW and PFTAU) (“Perception”), today announced they have entered into a definitive business combination agreement that would result in RBio Energy becoming a publicly traded company (the “Transaction”). Perception currently has over $42 million of cash in the trust account established...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.